 | Highlight 2009.11.9  For Shareholders |
| Utilizing its strengths in antibody technologies and biotechnologies, Kyowa Hakko Kirin is eager to discover new drugs and to contribute to society. |
- 2010.07.28
- 2010.07.28
-
2010.07.28
Appendix to the Fiscal 2010 Interim Consolidated Financial Statements
-
2010.07.28
Consolidated Financial Summary Fiscal 2010 Interim (January 1, 2010 - June 30, 2010)
- 2010.06.03
-
2010.04.30
Appendix to the Fiscal 2010 First Quarter Consolidated Financial Statements
-
2010.04.28
Consolidated Financial Summary:
First Quarter of the Fiscal Year to December 2010 - 2009.11.12
-
2009.11.12
Appendix to the Consolidated Financial Statements Fiscal 2009 Interim
(69KB)
- 2009.08.20
Financial Information through Euroland.com
Corporate Information (English)
Corporate Information (Chinese)
Fact Sheet (English)
Share Graph (English)
Share Price Search (English)